The funding will help fund phase 1 and phase 2 proof-of-concept studies for lead candidates CTX203 and CTX114. Investigators advised clinicians of the potential for dystrophies that mimic age-related ...

Aviceda Therapeutics recently appointed Jeffrey Nau, PhD, MMS, as chief executive officer. Nau comes to Aviceda with more than 20 years of experience leading and expanding biotechnology and ...

Atsena Therapeutics announced in a press release that the FDA granted its gene therapy product candidate, ATSN-201, the regenerative medicine advanced therapy (RMAT) designation to treat X-linked ...

According to the company, the axitinib injectable suspension achieved all primary and secondary outcomes and maintained stable visual acuity and anatomical control over 9 months. There were no ocular ...

A recent study of AEYE-DS AI technology used in conjunction with the Topcon NW500 resulted in exceptional clinical diagnostic efficacy.

A new study found that an artificial intelligence reading label system improves ophthalmologists' diagnostic accuracy for retinal diseases and could be valuable in future medical education. A new ...

Pykus Therapeutics announced it has completed enrollment in its pilot study, PYK-2101-RD00, evaluating PYK-2101, a focal hydrogel retinal sealant, in patients undergoing surgery for detached retina.

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely monitored for its onset. Taiwanese investigators found in their cohort ...

Novelty Nobility, a Korean antibody drug discovery company, recently announced it has been selected to join JLABS Korea. 1 JLABS, part of Johnson & Johnson’s global incubator network, supports ...

Rebecca Silverman, MD, and associates advised evaluating the cerebrospinal fluid (CSF) in patients suspected of having vitreoretinal lymphoma to ensure that vitreoretinal lymphoma is not missed. 1 She ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in future clinical trials.